Premium
BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced
Author(s) -
Chang Xinyue,
Augusto Gilles Sousa,
Liu Xuelan,
Kündig Thomas M.,
Vogel Monique,
Mohsen Mona O.,
Bachmann Martin F.
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14893
Subject(s) - neutralization , antibody , vaccination , virology , neutralizing antibody , glycoprotein , immunization , immunology , biology , covid-19 , immune system , medicine , genetics , infectious disease (medical specialty) , disease , pathology